New diagnostic strategy aims to end the diagnostic odyssey for rare peroxisomal diseases
NCT ID NCT03163771
First seen Jan 09, 2026 · Last updated May 12, 2026 · Updated 19 times
Summary
This study tested a new approach to diagnose peroxisomal diseases, a group of rare genetic disorders. The strategy uses advanced metabolic and genetic testing in patients with suspected symptoms. Researchers aimed to reduce the long delays in diagnosis. The study included 8 participants from four hospitals in France.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIAGNOSES DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Département de Pédiatrie, Unité de Génétique Clinique, CHU d'Amiens
Amiens, 80054, France
-
Hôpital Jeanne de Flandres, CHRU
Lille, France
-
Pédiatrie, CHU Clémenceau de Caen
Caen, 40433, France
-
Pédiatrie, Pavillon Mère et Enfant, CHU Ch. Nicolle de Rouen
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.